- Joined
- Nov 27, 2002
- Messages
- 7,890
- Reaction score
- 756
So continuing on with Quinns cocaine in the ED theme we got some new literature in last months Annals.
There was a study by Datillo, et al that concludes that patients who present with chest pain and had positive cocaine tests actually do better on beta blockers despite the widely held but possibly erroneous view that beta blockers + cocaine = unopposed alpha and agitation, hyperthermia, seizures and death.
But wait! There are some editorials on the subject:
Since editorials dont have abstracts and it would be a copyright violation to post the text Ill cite and summarize. Hoffman argues that the morbidity and mortality from cocaine induced chest pain is quite low (on the order of 5%) so exposing these patients to a known, deadly if rare drug interaction is unwarranted. He is saying we should stick with the status quo and avoid beta blockers in cocaine users. He goes as far as to say that doing a study to try to figure this out would be premature and dangerous.
But wait, theres another editorial:
Freeman and Feldman argue that the traditional view that beta blockers must be avoided in cocaine use is toxicomythology and that it is an entranched but inaccurate belief. They argue that more study is warranted but they dont go so far as to say that current practice should change.
So what are we to do with all this? I took note because I routinely give the speech to students and residents about beta blockers + cocaine = unopposed alpha. My first thought was Have I been talking out of my ***? Turns out probably not, but the winds of change may be starting to blow and in a few years we may be practicing differently.
Another point for the students and residents in EM is that additional retrospective studies are needed. The Dattilo paper was based on a retrospective chart review of patients admitted for chest pain who and received beta blockers and had positive cocaine tests. They had 363 patients. We need to know if this papers findings extend to other centers and greater numbers. Retrospective chart review studies like this are relatively easy to do and are within the reach of resident research projects.
If we judge possible research projects by the triumvirate of Is it novel, is it interesting, will it change practice? such projects would meet 2 out of 3.
There was a study by Datillo, et al that concludes that patients who present with chest pain and had positive cocaine tests actually do better on beta blockers despite the widely held but possibly erroneous view that beta blockers + cocaine = unopposed alpha and agitation, hyperthermia, seizures and death.
Beta-blockers are associated with reduced risk of myocardial infarction after cocaine use.
Annals of Emergency Medicine - Volume 51, Issue 2 (February 2008)
Abstract:
STUDY OBJECTIVE: Beta-blocker use is associated with coronary artery spasm after cocaine administration but also decreases mortality in patients with myocardial infarction or systolic dysfunction. We conduct a retrospective cohort study to analyze the safety of beta-blockers in patients with positive urine toxicology results for cocaine. METHODS: The cohort consisted of 363 consecutive telemetry and ICU patients who were admitted to a municipal hospital and had positive urine toxicology results for cocaine during a 5-year period (307 patients). Fifteen patients with uncertain history of beta-blocker use before admission were excluded. The primary outcome measure was myocardial infarction; secondary outcome measure was inhospital mortality. Logistic regression analysis using generalized estimating equations models and propensity scores compared outcomes. RESULTS: Beta-blockers were given in 60 of 348 admissions. The incidence of myocardial infarction after administration of beta-blocker was significantly lower than without treatment (6.1% versus 26.0%; difference in proportion 19.9%; 95% confidence interval [CI] 10.3% to 30.0%). One of 14 deaths occurred in patients who received beta-blockade (incidence 1.7% versus 4.5% without beta-blockade; difference in proportion 2.8%; 95% CI -1.2% to 6.7%). Multivariate analysis showed that use of beta-blockers significantly reduced the risk of myocardial infarction (odds ratio 0.06; 95% CI 0.01 to 0.61). CONCLUSION: In our cohort, administration of beta-blockers was associated with reduction in incidence of myocardial infarction after cocaine use. The benefit of beta-blockers on myocardial function may offset the risk of coronary artery spasm.
Citation:
Beta-blockers are associated with reduced risk of myocardial infarction after cocaine use.
Dattilo PB - Ann Emerg Med - 01-FEB-2008; 51(2): 117-25
From NIH/NLM MEDLINE
NLM Citation ID:17583376 (PubMed ID)
Comment:Ann Emerg Med. 2008 Feb;51(2):127-9
PubMed ID: 17889405
Full Source Title:
Annals of emergency medicine
Publication Type:
Journal Article
Language:
English
Author Affiliation:
Department of Medicine, Jacobi Medical Center, Bronx, NY 10461, USA.
Authors:
Dattilo PB; Hailpern SM; Fearon K; Sohal D; Nordin C
But wait! There are some editorials on the subject:
Cocaine and beta-blockers: should the controversy continue?
Hoffman RS - Ann Emerg Med - 01-FEB-2008; 51(2): 127-9
From NIH/NLM MEDLINE
NLM Citation ID:17889405 (PubMed ID)
Comment:Comment On: Ann Emerg Med. 2008 Feb;51(2):117-25
PubMed ID: 17583376
Full Source Title: Annals of emergency medicine
Publication Type: Comment; Editorial
Language: English
Authors: Hoffman RS
Since editorials dont have abstracts and it would be a copyright violation to post the text Ill cite and summarize. Hoffman argues that the morbidity and mortality from cocaine induced chest pain is quite low (on the order of 5%) so exposing these patients to a known, deadly if rare drug interaction is unwarranted. He is saying we should stick with the status quo and avoid beta blockers in cocaine users. He goes as far as to say that doing a study to try to figure this out would be premature and dangerous.
But wait, theres another editorial:
Cocaine, Myocardial Infarction, and β-Blockers: Time to Rethink the Equation?Annals of Emergency Medicine - Volume 51, Issue 2 (February 2008) - Copyright © 2008 American College of Emergency Physicians
Cocaine, Myocardial Infarction, and β-Blockers: Time to Rethink the Equation?
Kalev Freeman, MD, PhDa,
James A. Feldman, MD, MPHb
a University of Vermont College of Medicine, Department of Surgery, Burlington, VT
b Boston University School of Medicine, Department of Emergency Medicine, Boston, MA.
* Address for correspondence: Kalev Freeman, MD, PhD, University of Vermont College of Medicine, Department of Surgery, Burlington, VT; 802-847-5354, fax 802-847-5579
E-mail address: [email protected]
Supervising editor: Richard C. Dart, MD, PhD
Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article, that might create any potential conflict of interest. The authors have stated that no such relationships exist. See the Manuscript Submission Agreement in this issue for examples of specific conflicts covered by this statement.
Publication date: Available online October 15, 2007.
Earn CME Credit: Continuing Medical Education for this article is available at: www.ACEP-EMedHome.com .
Reprints not available from the authors.
PII S0196-0644(07)01449-7
Freeman and Feldman argue that the traditional view that beta blockers must be avoided in cocaine use is toxicomythology and that it is an entranched but inaccurate belief. They argue that more study is warranted but they dont go so far as to say that current practice should change.
So what are we to do with all this? I took note because I routinely give the speech to students and residents about beta blockers + cocaine = unopposed alpha. My first thought was Have I been talking out of my ***? Turns out probably not, but the winds of change may be starting to blow and in a few years we may be practicing differently.
Another point for the students and residents in EM is that additional retrospective studies are needed. The Dattilo paper was based on a retrospective chart review of patients admitted for chest pain who and received beta blockers and had positive cocaine tests. They had 363 patients. We need to know if this papers findings extend to other centers and greater numbers. Retrospective chart review studies like this are relatively easy to do and are within the reach of resident research projects.
If we judge possible research projects by the triumvirate of Is it novel, is it interesting, will it change practice? such projects would meet 2 out of 3.